yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
2
Q33412937-08622822-A542-45AE-B7C2-5A1FC36545C5
Q33412937-08622822-A542-45AE-B7C2-5A1FC36545C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33412937-08622822-A542-45AE-B7C2-5A1FC36545C5
Bone marrow hypocellularity does not affect tolerance or efficacy of azacitidine in patients with higher-risk myelodysplastic syndromes.
P2860
Q33412937-08622822-A542-45AE-B7C2-5A1FC36545C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33412937-08622822-A542-45AE-B7C2-5A1FC36545C5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
810136e0cdf09f8cc4f121175d1f5a3ca954a3b5
P2860
Hypocellular myelodysplastic syndromes (MDS): new proposals.